HomeCompareIPZYF vs SBUX

IPZYF vs SBUX: Dividend Comparison 2026

IPZYF yields 248.29% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPZYF wins by $441.24M in total portfolio value
10 years
IPZYF
IPZYF
● Live price
248.29%
Share price
$0.81
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$441.40M
Annual income
$246,281,693.35
Full IPZYF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — IPZYF vs SBUX

📍 IPZYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPZYFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPZYF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IPZYF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPZYF
Annual income on $10K today (after 15% tax)
$21,104.90/yr
After 10yr DRIP, annual income (after tax)
$209,339,439.35/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, IPZYF beats the other by $209,278,973.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPZYF + SBUX for your $10,000?

IPZYF: 50%SBUX: 50%
100% SBUX50/50100% IPZYF
Portfolio after 10yr
$220.79M
Annual income
$123,176,414.90/yr
Blended yield
55.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

IPZYF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
3.6
Piotroski
4/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPZYF buys
0
SBUX buys
0
No recent congressional trades found for IPZYF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPZYFSBUX
Forward yield248.29%2.84%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$441.40M$167.0K
Annual income after 10y$246,281,693.35$71,136.45
Total dividends collected$420.53M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: IPZYF vs SBUX ($10,000, DRIP)

YearIPZYF PortfolioIPZYF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$35,529$24,829.30$11,121$420.68+$24.4KIPZYF
2$120,462$82,445.57$12,548$648.40+$107.9KIPZYF
3$390,138$261,244.20$14,440$1,013.98+$375.7KIPZYF
4$1,208,185$790,736.66$17,068$1,617.30+$1.19MIPZYF
5$3,581,320$2,288,562.15$20,912$2,649.52+$3.56MIPZYF
6$10,172,004$6,339,991.53$26,875$4,499.29+$10.15MIPZYF
7$27,713,431$16,829,387.07$36,771$8,014.12+$27.68MIPZYF
8$72,505,096$42,851,724.63$54,542$15,197.11+$72.45MIPZYF
9$182,356,681$104,776,228.36$89,602$31,242.49+$182.27MIPZYF
10$441,403,342$246,281,693.35$167,011$71,136.45+$441.24MIPZYF

IPZYF vs SBUX: Complete Analysis 2026

IPZYFStock

IP Group Plc is a private equity and venture capital firm specializing in seed, early stage, start-up, incubation, growth capital, and mature financing. The firm also provides seed capital financing to spin out companies from the universities. It seeks to invest in the life sciences, physical sciences, energy & renewables, medical equipment and supplies, healthcare, technology, cleantech, intellectual property, pharmaceuticals & biotechnology, information technology & communications, and chemicals & materials. It also provides support for its university partners' intellectual property commercialization activities, as well as in the identification of intellectual property. It typically invests between £0.5 million ($0.75 million) and £1 million ($1.50 million) per investment. The firm prefers to takes equity positions in its portfolio companies. IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Wilmington, Delaware; Hong Kong S.A.R., Hong Kong and Melbourne, Australia.

Full IPZYF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this IPZYF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPZYF vs SCHDIPZYF vs JEPIIPZYF vs OIPZYF vs KOIPZYF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.